You are here

  • Home
  • Archive
  • Volume 49, Issue 3
  • Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects

Article Text

Article menu
Download PDFPDF
Helicobacter pylori
Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects
  1. Y Yamajia,c,
  2. T Mitsushimab,c,
  3. H Ikumab,
  4. M Okamotoa,c,
  5. H Yoshidaa,
  6. T Kawabea,
  7. Y Shiratoria,
  8. K Saitob,
  9. K Yokouchic,
  10. M Omataa
  1. aDivision of Gastroenterology, Department of Internal Medicine, University of Tokyo, Tokyo, Japan, bDepartment of Gastroenterology, Kameda General Hospital, Kamogawa, Japan, cMakuhari Clinic, Chiba, Japan
  1. Dr Y Yamaji, Second Department of Internal Medicine, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.yamaji-tky{at}umin.ac.jp

Abstract

BACKGROUND The relationship between Helicobacter pylori and reflux oesophagitis remains controversial.

AIMS To evaluate the relationship between H pylori and reflux oesophagitis in a large number of Japanese subjects.

SUBJECTS A total of 5732 consecutive Japanese subjects during a health screening were enrolled.

METHODS Gastrointestinal endoscopy was performed on all subjects. We simultaneously measured serum anti-H pylori antibody and pepsinogen as markers of H pylori infection together with gastric atrophy. The risk of reflux oesophagitis was evaluated in relation to these markers, and the results were compared with those of gastric cancer.

RESULTS Reflux oesophagitis was found in 108 subjects. Both positivity forH pylori antibody (adjusted odds ratio (OR) 0.67 (95% confidence interval 0.45–1.0)) and “low” pepsinogen indicating gastric atrophy (OR 0.35 (0.18–0.68)) were negatively associated with reflux oesophagitis. After subjects were classified into four groups based on positivity or negativity for H pylori antibody and “low” pepsinogen, the prevalence of reflux oesophagitis showed a decreasing trend as H pylori induced gastric atrophy became more severe. The risk of gastric cancer showed an increasing trend, exactly the opposite to that of reflux oesophagitis.

CONCLUSIONS Analysis of a large series of Japanese subjects revealed a decreasing prevalence of reflux oesophagitis in conjunction with progress of gastric atrophy induced by H pylori infection. This pattern was completely opposite to that of gastric cancer cases. A protective role of H pylori for reflux oesophagitis through the development of gastric atrophy has been suggested.

  • Helicobacter pylori
  • oesophagitis
  • gastro-oesophageal reflux disease
  • atrophic gastritis
  • gastric cancer

  • Abbreviations used in this paper

    GORD
    gastro-oesophageal reflux disease
    OR
    odds ratio

    • https://doi.org/10.1136/gut.49.3.335

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    • Abbreviations used in this paper

      GORD
      gastro-oesophageal reflux disease
      OR
      odds ratio
      • View Full Text

      Linked Articles